Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Retained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Total Debt (2021 - 2024)

Historic Total Debt for Abivax (ABVX) over the last 5 years, with Q3 2025 value amounting to $37.7 million.

  • Abivax's Total Debt changed N/A to $37.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.7 million, marking a year-over-year change of. This contributed to the annual value of $38.9 million for FY2024, which is 5333.7% down from last year.
  • Latest data reveals that Abivax reported Total Debt of $37.7 million as of Q3 2025.
  • Abivax's 5-year Total Debt high stood at $82.9 million for Q4 2023, and its period low was $13.0 million during Q4 2021.
  • In the last 5 years, Abivax's Total Debt had a median value of $39.3 million in 2024 and averaged $42.0 million.
  • As far as peak fluctuations go, Abivax's Total Debt skyrocketed by 29145.37% in 2022, and later crashed by 5308.64% in 2024.
  • Abivax's Total Debt (Quarter) stood at $13.0 million in 2021, then soared by 291.45% to $50.8 million in 2022, then surged by 63.17% to $82.9 million in 2023, then tumbled by 53.09% to $38.9 million in 2024, then fell by 3.0% to $37.7 million in 2025.
  • Its last three reported values are $37.7 million in Q3 2025, $43.4 million for Q2 2025, and $39.8 million during Q1 2025.